105 related articles for article (PubMed ID: 23582658)
1. Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry.
Sarasa L; Allué JA; Pesini P; González-Martínez A; Sarasa M
Neurobiol Aging; 2013 Sep; 34(9):2125-32. PubMed ID: 23582658
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
Portelius E; Gustavsson MK; Zetterberg H; Andreasson U; Blennow K
Neurodegener Dis; 2012; 10(1-4):138-40. PubMed ID: 22302034
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.
Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M
J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology.
Maddalena AS; Papassotiropoulos A; Gonzalez-Agosti C; Signorell A; Hegi T; Pasch T; Nitsch RM; Hock C
Neurodegener Dis; 2004; 1(4-5):231-5. PubMed ID: 16908995
[TBL] [Abstract][Full Text] [Related]
5. Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.
Portelius E; Westman-Brinkmalm A; Zetterberg H; Blennow K
J Proteome Res; 2006 Apr; 5(4):1010-6. PubMed ID: 16602710
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
[TBL] [Abstract][Full Text] [Related]
7. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
[TBL] [Abstract][Full Text] [Related]
8. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
9. Aminoterminally truncated and oxidized amyloid-β peptides in the cerebrospinal fluid of Alzheimer's disease patients.
Bibl M; Gallus M; Welge V; Esselmann H; Wiltfang J
J Alzheimers Dis; 2012; 29(4):809-16. PubMed ID: 22460324
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.
Bibl M; Gallus M; Welge V; Lehmann S; Sparbier K; Esselmann H; Wiltfang J
Proteomics Clin Appl; 2012 Apr; 6(3-4):163-9. PubMed ID: 22532452
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
[TBL] [Abstract][Full Text] [Related]
12. Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
Portelius E; Van Broeck B; Andreasson U; Gustavsson MK; Mercken M; Zetterberg H; Borghys H; Blennow K
J Alzheimers Dis; 2010; 21(3):1005-12. PubMed ID: 20634579
[TBL] [Abstract][Full Text] [Related]
13. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
Portelius E; Zetterberg H; Andreasson U; Brinkmalm G; Andreasen N; Wallin A; Westman-Brinkmalm A; Blennow K
Neurosci Lett; 2006 Dec; 409(3):215-9. PubMed ID: 17049739
[TBL] [Abstract][Full Text] [Related]
14. Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.
Albertini V; Benussi L; Paterlini A; Glionna M; Prestia A; Bocchio-Chiavetto L; Amicucci G; Galluzzi S; Adorni A; Geroldi C; Binetti G; Frisoni GB; Ghidoni R
Electrophoresis; 2012 Dec; 33(24):3738-44. PubMed ID: 23161113
[TBL] [Abstract][Full Text] [Related]
15. A novel pathway for amyloid precursor protein processing.
Portelius E; Price E; Brinkmalm G; Stiteler M; Olsson M; Persson R; Westman-Brinkmalm A; Zetterberg H; Simon AJ; Blennow K
Neurobiol Aging; 2011 Jun; 32(6):1090-8. PubMed ID: 19604603
[TBL] [Abstract][Full Text] [Related]
16. The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.
Pannee J; Törnqvist U; Westerlund A; Ingelsson M; Lannfelt L; Brinkmalm G; Persson R; Gobom J; Svensson J; Johansson P; Zetterberg H; Blennow K; Portelius E
Neurosci Lett; 2014 Jun; 573():7-12. PubMed ID: 24796810
[TBL] [Abstract][Full Text] [Related]
17. Dominance of amyloid precursor protein sequence over host cell secretases in determining beta-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry.
Du P; Wood KM; Rosner MH; Cunningham D; Tate B; Geoghegan KF
J Pharmacol Exp Ther; 2007 Mar; 320(3):1144-52. PubMed ID: 17202404
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid β-Amyloid turnover in the mouse, dog, monkey and human evaluated by systematic quantitative analyses.
Lu Y; Barton HA; Leung L; Zhang L; Hajos-Korcsok E; Nolan CE; Liu J; Becker SL; Wood KM; Robshaw AE; Taylor CK; O'Neill BT; Brodney MA; Riddell D
Neurodegener Dis; 2013; 12(1):36-50. PubMed ID: 22922480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
